These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22998109)

  • 1. Better cancer biomarker discovery through better study design.
    Rundle A; Ahsan H; Vineis P
    Eur J Clin Invest; 2012 Dec; 42(12):1350-9. PubMed ID: 22998109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simulation study of control sampling methods for nested case-control studies of genetic and molecular biomarkers and prostate cancer progression.
    Wang MH; Shugart YY; Cole SR; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):706-11. PubMed ID: 19258478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study Design Considerations for Cancer Biomarker Discoveries.
    Zheng Y
    J Appl Lab Med; 2018 Sep; 3(2):282-289. PubMed ID: 30828695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design options for molecular epidemiology research within cohort studies.
    Rundle AG; Vineis P; Ahsan H
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1899-907. PubMed ID: 16103435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the quality of biomarker discovery research: the right samples and enough of them.
    Pepe MS; Li CI; Feng Z
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):944-50. PubMed ID: 25837819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease.
    Ganna A; Reilly M; de Faire U; Pedersen N; Magnusson P; Ingelsson E
    Am J Epidemiol; 2012 Apr; 175(7):715-24. PubMed ID: 22396388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point.
    Graziano F; Valsecchi MG; Rebora P
    BMC Med Res Methodol; 2021 Apr; 21(1):93. PubMed ID: 33941092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse probability weighting in nested case-control studies with additional matching--a simulation study.
    Støer NC; Samuelsen SO
    Stat Med; 2013 Dec; 32(30):5328-39. PubMed ID: 24132909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical methods for analysis of combined biomarker data from multiple nested case-control studies.
    Cheng C; Sloan A; Wang M
    Stat Methods Med Res; 2021 Aug; 30(8):1944-1959. PubMed ID: 34232834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of controls in case-control studies. III. Design options.
    Wacholder S; Silverman DT; McLaughlin JK; Mandel JS
    Am J Epidemiol; 1992 May; 135(9):1042-50. PubMed ID: 1595690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sampling strategies in nested case-control studies.
    Langholz B; Clayton D
    Environ Health Perspect; 1994 Nov; 102 Suppl 8(Suppl 8):47-51. PubMed ID: 7851330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker discovery for heterogeneous diseases.
    Wallstrom G; Anderson KS; LaBaer J
    Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):747-55. PubMed ID: 23462916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical methods for biomarker data pooled from multiple nested case-control studies.
    Sloan A; Smith-Warner SA; Ziegler RG; Wang M
    Biostatistics; 2021 Jul; 22(3):541-557. PubMed ID: 31750898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design.
    Pepe MS; Feng Z; Janes H; Bossuyt PM; Potter JD
    J Natl Cancer Inst; 2008 Oct; 100(20):1432-8. PubMed ID: 18840817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unbiased data analytic strategies to improve biomarker discovery in precision medicine.
    Khan SR; Manialawy Y; Wheeler MB; Cox BJ
    Drug Discov Today; 2019 Sep; 24(9):1735-1748. PubMed ID: 31158511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical consideration for clinical biomarker research in bladder cancer.
    Shariat SF; Lotan Y; Vickers A; Karakiewicz PI; Schmitz-Dräger BJ; Goebell PJ; Malats N
    Urol Oncol; 2010; 28(4):389-400. PubMed ID: 20610277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel analysis method for biomarker identification based on horizontal relationship: identifying potential biomarkers from large-scale hepatocellular carcinoma metabolomics data.
    Su B; Luo P; Yang Z; Yu P; Li Z; Yin P; Zhou L; Fan J; Huang X; Lin X; Qiao Y; Xu G
    Anal Bioanal Chem; 2019 Sep; 411(24):6377-6386. PubMed ID: 31384984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting controls for assessing interaction in nested case-control studies.
    Cologne J; Langholz B
    J Epidemiol; 2003 Jul; 13(4):193-202. PubMed ID: 12934962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of incidence and prognosis from 'extreme' case-control designs.
    Salim A; Ma X; Fall K; Andrén O; Reilly M
    Stat Med; 2014 Dec; 33(30):5388-98. PubMed ID: 24980445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.